
EVERGREENING ON TRIAL: AN ANALYSIS OF NOVO NORDISK AS V. DR REDDY’S LABORATORIES LIMITED & ANR
INTRODUCTION In the landmark ruling of Novo Nordisk AS v/s Dr Reddy’s Laboratories Limited & Anr. (December 2025), the Hon’ble Delhi High Court addressed one of the most significant pharmaceutical patent dispute. The case involves Semaglutide, an active pharmaceutical ingredient used in blockbuster drugs such as Ozempic and Wegovy which








